Dr. Antonio Jimenez Jimenez presented the ACCESS trial at the EHA 2024 – Sylvester Comprehensive Cancer Center

Sylvester Comprehensive Cancer Center recently shared a post on X:

“Our very own Dr. Antonio Jimenez Jimenez presented the ACCESS trial at the European Hematology Association Annual Meeting.

The trial shows that adults with blood cancers receiving mismatched peripheral blood stem cell transplants exhibited excellent survival rates and a low incidence of life-threatening graft-versus-host disease, safely expanding transplant access to patients of all races and ethnicities.”

Source: Sylvester Comprehensive Cancer Center/X